Literature DB >> 15262505

Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.

Mamuka Kvaratskhelia1, Patrick K Clark, Sonja Hess, Deborah C Melder, Mark J Federspiel, Stephen H Hughes.   

Abstract

We used enzymatic digestion and mass spectrometry to identify the sites of glycosylation on the SU component of the Avian Sarcoma/Leukosis virus (ASLV) Envelope Glycoprotein (Subgroup A). The analysis was done with an SU(A)-rIgG fusion protein that binds the cognate receptor (Tva) specifically. PNGase F removed all the carbohydrate from the SU(A)-rIgG fusion. PNGase F is specific for N-linked carbohydrates; this shows that all the carbohydrate on SU(A) is N-linked. There are 10 modified aspargines in SU(A) (N17, N59, N80, N97, N117, N196, N230, N246, N254, and N330). All conform to the consensus site for N-linked glycosylation NXS/T. There is one potential glycosylation site (N236) that is not modified. Removing most of the carbohydrate from the mature SU(A)-rIgG by PNGase F treatment greatly reduces the ability of the protein to bind Tva, suggesting that carbohydrate may play a direct role in receptor binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262505     DOI: 10.1016/j.virol.2004.05.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Identification of the N-linked glycosylation sites of vitamin K-dependent carboxylase and effect of glycosylation on carboxylase function.

Authors:  Jian-Ke Tie; Mei-Yan Zheng; R Marshall Pope; David L Straight; Darrel W Stafford
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

2.  The architecture and chemical stability of the archaeal Sulfolobus turreted icosahedral virus.

Authors:  Reza Khayat; Chi-yu Fu; Alice C Ortmann; Mark J Young; John E Johnson
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.

Authors:  Sue E Delos; Jesse A Godby; Judith M White
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Simple, automated, high resolution mass spectrometry method to determine the disulfide bond and glycosylation patterns of a complex protein: subgroup A avian sarcoma and leukosis virus envelope glycoprotein.

Authors:  Gennett M Pike; Benjamin J Madden; Deborah C Melder; M Cristine Charlesworth; Mark J Federspiel
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

5.  The receptor for the subgroup C avian sarcoma and leukosis viruses, Tvc, is related to mammalian butyrophilins, members of the immunoglobulin superfamily.

Authors:  Daniel Elleder; Volodymir Stepanets; Deborah C Melder; Filip Senigl; Josef Geryk; Petr Pajer; Jirí Plachý; Jirí Hejnar; Jan Svoboda; Mark J Federspiel
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 6.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

7.  The Bipartite Sequence Motif in the N and C Termini of gp85 of Subgroup J Avian Leukosis Virus Plays a Crucial Role in Receptor Binding and Viral Entry.

Authors:  Yao Zhang; Mengmeng Yu; Lixiao Xing; Peng Liu; Yuntong Chen; Fangfang Chang; Suyan Wang; Yuanling Bao; Muhammad Farooque; Xinyi Li; Xiaolu Guan; Yongzhen Liu; Aijing Liu; Xiaole Qi; Qing Pan; Yanping Zhang; Li Gao; Kai Li; Changjun Liu; Hongyu Cui; Xiaomei Wang; Yulong Gao
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

8.  Quantitative iTRAQ LC-MS/MS proteomics reveals the proteome profiles of DF-1 cells after infection with subgroup J Avian leukosis virus.

Authors:  Xiaofei Li; Qi Wang; Yanni Gao; Xiaole Qi; Yongqiang Wang; Honglei Gao; Yulong Gao; Xiaomei Wang
Journal:  Biomed Res Int       Date:  2015-01-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.